Solazyme Announces New Senior Director, Biofuel Development

    MENLO PARK, Calif., March 5 /PRNewswire/ -- Solazyme, a leading algal
 biotechnology company, today announced that it has named Dr. Donald E.
 Trimbur to the position of Senior Director, Biofuel Development.
     Dr. Trimbur is a metabolic engineer and microbiologist with more than
 twenty years in academic and industrial biotechnology research and
 development. He is an inventor on numerous patents and patent applications
 in the fields of industrial biotechnology and metabolic engineering. He was
 most recently Head of the Protein Science research group of Genencor
 International, Inc. (www.genencor.com ), where he spent thirteen years.
 While at Genencor, Dr. Trimbur also held a number of other positions,
 including Leader of Pathway Design in the Metabolic Pathway Group and Head
 of Functional Genomics. During this period he led industrial biotechnology
 projects in a number of business areas, including his work on the
 ground-breaking metabolic engineering project for highly efficient
 bioproduction of 1, 3- propanediol with Genencor's partner Dupont. Dr
 Trimbur was a member of the first editorial board of the influential
 journal Metabolic Engineering.
     "I have known Don for years and was thrilled that he was interested in
 joining us," said Dr. Tony Day, VP of Research and Development at Solazyme.
 "We are lucky to have a metabolic engineer of his caliber and with his
 extensive industrial background to help drive the direction of our biofuels
 work."
     Dr. Trimbur received his Ph.D. in microbiology from Cornell University.
 He then performed postdoctoral fellowships at both the University of
 British Columbia, where he worked with Dr. Stephen Withers on enzyme
 mechanisms of beta-glucosidases, and at Pennsylvania State University in
 the lab of Dr. Jean Benchley, where he studied psychophilic enzymes.
     More information on Solazyme and Dr. Trimbur can be found online at
 www.solazyme.com
     About Solazyme:
     Founded in 2003 in Menlo Park, California, Solazyme is devoted to
 harnessing the energy-harvesting machinery of various species of algae to
 produce valuable products. The Company utilizes proprietary genetic
 engineering methods to develop and optimize commercially relevant
 biochemical pathways for production of biofuels and health and wellness
 materials. For more information, please visit our website:
 http://www.solazyme.com or contact Jonathan Wolfson at 650-780-4777.
 
 

SOURCE Solazyme, Inc.